Ausgabe 4/2017
Inhalt (10 Artikel)
Current Opinion
New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?
Michael Berry, Brijesh V. Patel, Stephen J. Brett
Review Article
Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview
Pieter Hindryckx, Gregor Novak, Niels Vande Casteele, Reena Khanna, Debby Laukens, Jairath Vipul, Brian G. Feagan
Erratum
Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview
Pieter Hindryckx, Gregor Novak, Niels Vande Casteele, Reena Khanna, Debby Laukens, Vipul Jairath, Brian G. Feagan
Review Article
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate Jr
Systematic Review
Abuse and Misuse of Pregabalin and Gabapentin
Kirk E. Evoy, Megan D. Morrison, Stephen R. Saklad
Original Research Article
Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence
Joshua J. Gagne, Jennifer M. Polinski, Wenlei Jiang, Sarah K. Dutcher, Jing Xie, Joyce Lii, Lisa A. Fulchino, Aaron S. Kesselheim
Adis Drug Evaluation
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
Lesley J. Scott